Showing results (1-10 of 618) with videos related to

Sort By:
Pageof 62
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 22, 2013
[DMARDs (disease-modifying antirheumatic drugs)]Eiichi Tanaka, Hisashi Yamanaka
Modern Rheumatology|August 30, 2017
Productivity loss of Japanese patients with rheumatoid arthritis - A cross-sectional surveyRosarin Sruamsiri, Jörg Mahlich, Eiichi Tanaka, et al.
Internal Medicine (Tokyo, Japan)|August 2, 2013
Methemoglobinemia induced by trimethoprim-sulfamethoxazole in a patient with systemic lupus erythematosusHidenaga Kawasumi, Eiichi Tanaka, Daisuke Hoshi, et al.
Journal of Bone and Mineral Metabolism|April 6, 2025
Increasing fracture incidence over 13 years in patients with rheumatoid arthritis from the IORRA cohortTakefumi Furuya, Eisuke Inoue, Hisashi Yamanaka, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 4, 2003
[Pharmacogenetics of disease modifying anti-rheumatic drugs]Atsuo Taniguchi, Wako Urano, Eiichi Tanaka, et al.
The Journal of Rheumatology|February 3, 2016
Clinical Characteristics and Cytokine Profiles of Organizing Pneumonia in Patients with Rheumatoid Arthritis Treated with or without BiologicsHidenaga Kawasumi, Takahisa Gono, Eiichi Tanaka, et al.
International Journal of Rheumatic Diseases|July 25, 2019
Risk of opportunistic infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis, using a Japanese health insurance databaseRyoko Sakai, Eiichi Tanaka, Hirokazu Nishina, et al.
Rheumatology International|May 18, 2010
Incidence of malignancy in Japanese patients with rheumatoid arthritisToru Yamada, Ayako Nakajima, Eisuke Inoue, et al.
Pageof 62